Breaking News, Promotions & Moves

AVI BioPharma

AVI BioPharma, Inc. has made three key leadership appointments to support the expansion of its drug discovery R&D capabilities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AVI BioPharma, Inc. has made three key leadership appointments to support the expansion of its drug discovery R&D capabilities. Graham Johnson, Ph.D., has been appointed senior vice president, Preclinical Development and Research, Patrick Iversen, Ph.D., has been appointed senior vice president of Research and Innovation, and Ryszard Kole, Ph.D., has been appointed senior vice president and an AVI Distinguished Scientist. All three will report to the company’s chief executive officer. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters